Serbia Pharmaceutical and Medical Goods Expenditure Share (2023)
Serbia's Pharmaceutical and Medical Goods Expenditure Share: 24.9 % of current health expenditure in 2023, +0.4pp YoY. Eurostat (HLTH_SHA11_HC), 2021–2023.
Serbia (2023)
24.9
% of current health expenditure
+0.4pp YoY
YoY Change
+0.4pp
percentage points
Trend
up
Series length
3
years of data
Data
| Year | % of current health expenditure | YoY Change |
|---|---|---|
| 2023 | 24.9 | +0.4pp |
| 2022 | 24.5 | -1.4pp |
| 2021 | 25.9 | n/a |
About this Dataset
Serbia recorded 24.9 % of current health expenditure in 2023. The latest change was +0.4pp. Across 2021–2023 the series ranges from 24.5 in 2022 to 25.9 in 2021.
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Serbia.
Data sourced from Eurostat via SDMX REST API. Values use harmonised methodology intended for cross-country comparison.
Frequently Asked Questions
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Serbia. It is published by Eurostat and updated annually.
The most recent observation covers 2023. Eurostat typically publishes this series with a lag of several months after the reference period. The series runs 2021–2023 (3 observations).
The series peaked at 25.9 % of current health expenditure in 2021 and reached its lowest recorded value of 24.5 in 2022. The latest reading of 24.9 in 2023 represents a change of +0.4pp.